Envveno Medical Corp Stock Performance
| NVNO Stock | USD 3.41 0.11 3.33% |
The firm shows a Beta (market volatility) of 0.68, which means possible diversification benefits within a given portfolio. As returns on the market increase, EnVVeno Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding EnVVeno Medical is expected to be smaller as well. At this point, enVVeno Medical Corp has a negative expected return of -0.62%. Please make sure to confirm EnVVeno Medical's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if enVVeno Medical Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days enVVeno Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return 0.29 | Five Day Return (5.26) | Year To Date Return (32.94) | Ten Year Return (97.39) | All Time Return (97.39) |
Last Split Factor 1:25 | Dividend Date 2020-11-30 | Last Split Date 2020-11-30 |
1 | Acquisition by Shrivastava Sanjay of 7211 shares of EnVVeno Medical at 6.7 subject to Rule 16b-3 | 08/30/2024 |
2 | enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing | 09/03/2024 |
3 | Acquisition by Glickman Marc H. of 265700 shares of EnVVeno Medical at 6.7 subject to Rule 16b-3 | 09/17/2024 |
4 | enVVeno Medical Corporation Announces Proposed Public Offering | 09/26/2024 |
5 | enVVeno Medical Corporation Announces Pricing of 15.0 Million Public Offering | 09/27/2024 |
6 | enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Pr... | 10/31/2024 |
7 | enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium | 11/20/2024 |
| Begin Period Cash Flow | 4.6 M |
EnVVeno |
EnVVeno Medical Relative Risk vs. Return Landscape
If you would invest 550.00 in enVVeno Medical Corp on August 27, 2024 and sell it today you would lose (209.00) from holding enVVeno Medical Corp or give up 38.0% of portfolio value over 90 days. enVVeno Medical Corp is currently does not generate positive expected returns and assumes 4.6438% risk (volatility on return distribution) over the 90 days horizon. In different words, 41% of stocks are less volatile than EnVVeno, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EnVVeno Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EnVVeno Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as enVVeno Medical Corp, and traders can use it to determine the average amount a EnVVeno Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1344
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVNO |
Estimated Market Risk
| 4.64 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.62 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EnVVeno Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EnVVeno Medical by adding EnVVeno Medical to a well-diversified portfolio.
EnVVeno Medical Fundamentals Growth
EnVVeno Stock prices reflect investors' perceptions of the future prospects and financial health of EnVVeno Medical, and EnVVeno Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EnVVeno Stock performance.
| Return On Equity | -0.59 | ||||
| Return On Asset | -0.37 | ||||
| Current Valuation | 12.57 M | ||||
| Shares Outstanding | 17.54 M | ||||
| Price To Book | 1.26 X | ||||
| EBITDA | (25.02 M) | ||||
| Net Income | (23.52 M) | ||||
| Cash And Equivalents | 37.48 M | ||||
| Cash Per Share | 3.96 X | ||||
| Total Debt | 1.4 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 20.79 X | ||||
| Book Value Per Share | 2.70 X | ||||
| Cash Flow From Operations | (18.86 M) | ||||
| Earnings Per Share | (1.29) X | ||||
| Market Capitalization | 59.8 M | ||||
| Total Asset | 48.63 M | ||||
| Retained Earnings | (130.04 M) | ||||
| Working Capital | 45.55 M | ||||
About EnVVeno Medical Performance
By examining EnVVeno Medical's fundamental ratios, stakeholders can obtain critical insights into EnVVeno Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that EnVVeno Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 36.85 | 32.76 | |
| Return On Tangible Assets | (0.48) | (0.51) | |
| Return On Capital Employed | (0.53) | (0.51) | |
| Return On Assets | (0.48) | (0.51) | |
| Return On Equity | (0.51) | (0.53) |
Things to note about enVVeno Medical Corp performance evaluation
Checking the ongoing alerts about EnVVeno Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for enVVeno Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| enVVeno Medical Corp generated a negative expected return over the last 90 days | |
| enVVeno Medical Corp has high historical volatility and very poor performance | |
| Net Loss for the year was (23.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| enVVeno Medical Corp currently holds about 37.48 M in cash with (18.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| enVVeno Medical Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium |
- Analyzing EnVVeno Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EnVVeno Medical's stock is overvalued or undervalued compared to its peers.
- Examining EnVVeno Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EnVVeno Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EnVVeno Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EnVVeno Medical's stock. These opinions can provide insight into EnVVeno Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.29) | Return On Assets (0.37) | Return On Equity (0.59) |
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.